OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
Carolyn F. Deacon
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 329

Showing 1-25 of 329 citing articles:

Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Mengwei Li, Xiaowei Chi, Ying Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 405

Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection
Kirsten Kulcsar, Christopher M. Coleman, Sarah E. Beck, et al.
JCI Insight (2019) Vol. 4, Iss. 20
Open Access | Times Cited: 369

Clinical Use of DPP-4 Inhibitors
Baptist Gallwitz
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 292

Diabetes and COVID-19: A systematic review on the current evidences
Alireza Abdi, Milad Jalilian, Pegah Ahmadi Sarbarzeh, et al.
Diabetes Research and Clinical Practice (2020) Vol. 166, pp. 108347-108347
Open Access | Times Cited: 254

Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
Sebastiano Bruno Solerte, Antonio Di Sabatino, Massimo Galli, et al.
Acta Diabetologica (2020) Vol. 57, Iss. 7, pp. 779-783
Open Access | Times Cited: 198

Pathobiology of the Klotho Antiaging Protein and Therapeutic Considerations
Gérald J. Prud’homme, Mervé Kurt, Qinghua Wang
Frontiers in Aging (2022) Vol. 3
Open Access | Times Cited: 118

The role of miRNAs in insulin resistance and diabetic macrovascular complications – A review
Sherif S. Abdel Mageed, Ahmed S. Doghish, Ahmed Ismail, et al.
International Journal of Biological Macromolecules (2023) Vol. 230, pp. 123189-123189
Closed Access | Times Cited: 72

DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature
Kunika Saini, Smriti Sharma, Yousuf Aziz Khan
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 65

Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence
Radica Z. Alicic, Emily J. Cox, Joshua J. Neumiller, et al.
Nature Reviews Nephrology (2020) Vol. 17, Iss. 4, pp. 227-244
Closed Access | Times Cited: 130

Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus
Hannah Kleine‐Weber, Simon Schroeder, Nadine Krüger, et al.
Emerging Microbes & Infections (2020) Vol. 9, Iss. 1, pp. 155-168
Open Access | Times Cited: 92

DPP-4 Inhibition and the Path to Clinical Proof
Bo Åhrén
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 86

Antidiabetic Potential of Marine Brown Algae—a Mini Review
M. D. T. L. Gunathilaka, Kalpa W. Samarakoon, P. Ranasinghe, et al.
Journal of Diabetes Research (2020) Vol. 2020, pp. 1-13
Open Access | Times Cited: 85

HIF-1α as a Mediator of Insulin Resistance, T2DM, and Its Complications: Potential Links With Obstructive Sleep Apnea
Agata Gabryelska, Filip Franciszek Karuga, Bartosz Szmyd, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 77

Dairy bioactive proteins and peptides: a narrative review
Nancy Auestad, Donald K. Layman
Nutrition Reviews (2021) Vol. 79, Iss. Supplement_2, pp. 36-47
Open Access | Times Cited: 74

Evaluation of Biological Activity of Natural Compounds: Current Trends and Methods
Carlos Barba‐Ostria, Saskya E. Carrera-Pacheco, Rebeca González‐Pastor, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4490-4490
Open Access | Times Cited: 64

Bioactive Potential of Brown Algae
Remya Rajan Renuka, Antony V. Samrot, Suresh Kumar, et al.
Adsorption Science & Technology (2022) Vol. 2022
Open Access | Times Cited: 63

New progress in drugs treatment of diabetic kidney disease
Junmin Wang, Hongjiao Xiang, Yifei Lü, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111918-111918
Open Access | Times Cited: 56

SARS-CoV-2: Receptor and Co-receptor Tropism Probability
Narges Eslami, Parisa Shiri Aghbash, Ali Shamekh, et al.
Current Microbiology (2022) Vol. 79, Iss. 5
Open Access | Times Cited: 51

SARS-CoV-2 cell entry beyond the ACE2 receptor
Shamila D. Alipoor, Mehdi Mirsaeidi
Molecular Biology Reports (2022) Vol. 49, Iss. 11, pp. 10715-10727
Open Access | Times Cited: 48

COVID-19: Diabetes Perspective—Pathophysiology and Management
Siva Dallavalasa, SubbaRao V. Tulimilli, Prakash Janhavi, et al.
Pathogens (2023) Vol. 12, Iss. 2, pp. 184-184
Open Access | Times Cited: 24

Potential Benefits of Antioxidant Phytochemicals in Type 2 Diabetes
Arman Arabshomali, Shadi Bazzazzadehgan, Fakhri Mahdi, et al.
Molecules (2023) Vol. 28, Iss. 20, pp. 7209-7209
Open Access | Times Cited: 23

In vitro and In silico evaluation of the antioxidant, anti-microbial and antihyperglycemic properties of giloy (Tinospora cordifolia L.) stem extract
Kimmy, Deepak Kumar Verma, Pawan Prabhakar, et al.
Biocatalysis and Agricultural Biotechnology (2024) Vol. 56, pp. 103059-103059
Closed Access | Times Cited: 8

Page 1 - Next Page

Scroll to top